Methicillin-Resistant Staphylococcus Aureus Drugs Market - Detailed Analysis and Forecast by 2024

1
Methicillin-Resistant Staphylococcus Aureus Drugs
Market Global Industry Analysis, Trends, Market
Size and Forecasts up to 2024
2
A latest report has been added to the wide
database of Methicillin-Resistant Staphylococcus
Aureus Drugs Market by Infinium Global Research.
This report studies the Methicillin-Resistant
Staphylococcus Aureus Drugs Market by drug class
(cephalosporin, lipopeptides, lipoglycopeptide,
folate antagonist, tetracycline, and
oxazolidinone), MOA (bactericidal drugs,
bacteriostatic), drug origin (synthetic drugs,
semisynthetic) market status and outlook of
global and major regions, from manufacturers, and
end industries. The objective of the study is to
identify market sizes of different segments
countries in recent years and to forecast the
values for the next six years. Methicillin-Resista
nt Staphylococcus Aureus Drugs Market provides
opportunities in micro markets for stakeholders
to invest along with the detailed analysis of
competitive landscape, latest trends, and product
offerings of the major companies in the
Methicillin- Resistant Staphylococcus Aureus
Drugs Market. According to report the
global methicillin-resistant staphylococcus
aureus drugs market is projected to grow at a
CAGR of 2.5 over the forecast period of
2018-2024. Segment Covered The report on global
methicillin-resistant staphylococcus aureus drugs
market covers segments such as, drug class, MOA
and drug origin. On the basis of drug class the
global methicillin-resistant staphylococcus
aureus drugs market is categorized into
cephalosporin, lipopeptides, lipoglycopeptide,
folate antagonist, tetracycline and
oxazolidinone. On the basis of MOA the global
methicillin-resistant staphylococcus aureus drugs
market is categorized into bactericidal drugs and
bacteriostatic. On the basis of drug origin the
global methicillin-resistant staphylococcus
aureus drugs market is categorized into synthetic
drugs and semisynthetic. Geographic Coverage The
report provides regional analysis covering
geographies such as North America, Europe,
Asia-Pacific, and Rest of the World. In
this section the key trends and market size for
each geography is provided over the period of
2016-2024. The countries covered in the North
America region include the U.S., Canada, and
Mexico while Asia-Pacific includes China, Japan,
India, South Korea, Malaysia, and among others.
Moreover, Germany, U.K., France, Spain, and Rest
of Europe are included in the European region.
The U.S. drives the growth in the North America
region as it is the largest market in the region.
The Asia-pacific region offers a substantial
potential for the market growth owing to rapid
growth in markets such as India and China. The
APAC region is projected to experience a growth
at a CAGR of x.x over the period of 2018-2024.
3

• Companies Profiled
• The report provides profiles of the
  companies in the global methicillin-resistant
  staphylococcus aureus drugs market such as,
• Theravance Biopharma, Basilea
  Pharmaceutica, Pfizer, Debiopharm Group,
  Merck, Allergan, Melinta Therapeutics,
  AmpliPhi Biosciences Corporation, KYORIN
  Pharmaceutical Co. Ltd. and Baxter International.
• Make an Enquiry - https//www.infiniumglobalresea
  rch.com/reports/enquiry/1187
• Report Highlights
• The report provides deep insights on demand
  forecasts, market trends and micro and
  macro indicators. In addition, this report
  provides insights on the factors that are driving
  and restraining the global methicillin-resistant
  staphylococcus aureus drugs market.
• Moreover, IGR-Growth Matrix analysis given
  in the report brings an insight on the
  investment areas that existing or new
  market players can consider. The report provides
  insights into the market using analytical tools
  such as Porter's five forces analysis and DRO
  analysis of methicillin-resistant
  staphylococcus aureus drugs market. Moreover,
  the study highlights current market trends
  and provides forecast from 2018-2024. We also
  have highlighted future trends in the
  methicillin-resistant staphylococcus aureus drugs
  market that will impact the demand during the
  forecast period. Moreover, the competitive
  analysis given in each regional market brings an
  insight on the market share of the leading
  players. This report will help manufacturers,
  suppliers and distributors of the
  methicillin-resistant staphylococcus aureus drugs
  market to understand the present and future
  trends in this market and formulate their
  strategies accordingly.
• Get a Sample Copy- https//www.infiniumglobalrese
  arch.com/reports/sample_request/1187
• Table of Contents-
• Preface
• Report Description
• Research Methods

4

• 1.3. Research Approaches
• Executive Summary
• Global Methicillin-resistant Staphylococcus
  Aureus Drugs Market Overview
• Introduction
• Market Dynamics
• Drivers
• Restraints
• Opportunities
• Porter's Five Forces Analysis
• IGR-Growth Matrix Analysis

5

• Folate Antagonist
• Tetracycline
• Oxazolidinone
• Global Methicillin-resistant Staphylococcus
  Aureus Drugs Market by MOA
• Bactericidal Drugs
• Bacteriostatic
• Global Methicillin-resistant Staphylococcus
  Aureus Drugs Market by Drug Origin
• Synthetic Drugs
• Semisynthetic
• Global Methicillin-resistant Staphylococcus
  Aureus Drugs Market by Region 2018-2024

6

• Europe
• Europe Methicillin-resistant Staphylococcus
  Aureus Drugs Market by Drug Class
• Europe Methicillin-resistant Staphylococcus
  Aureus Drugs Market by Moa
• Europe Methicillin-resistant Staphylococcus
  Aureus Drugs Market by Drug Origin
• Europe Methicillin-resistant Staphylococcus
  Aureus Drugs Market by Country
• Asia-Pacific
• Asia-Pacific Methicillin-resistant Staphylococcus
  Aureus Drugs Market by Drug Class
• Asia-Pacific Methicillin-resistant Staphylococcus
  Aureus Drugs Market by Moa
• Asia-Pacific Methicillin-resistant Staphylococcus
  Aureus Drugs Market by Drug Origin
• Asia-Pacific Methicillin-resistant Staphylococcus
  Aureus Drugs Market by Country

7

• Company Covered
• Theravance Biopharma
• Basilea Pharmaceutica
• Pfizer
• Debiopharm Group
• Merck
• Allergan
• Melinta Therapeutics
• Ampliphi Biosciences Corporation
• Kyorin Pharmaceutical Co. Ltd.